Bioavailability of aspirin and interacting influence of caffeine. 1978

S A Dahanukar, and S Pohujani, and U K Sheth

UI MeSH Term Description Entries
D008297 Male Males
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

S A Dahanukar, and S Pohujani, and U K Sheth
October 1989, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
S A Dahanukar, and S Pohujani, and U K Sheth
January 1986, European journal of drug metabolism and pharmacokinetics,
S A Dahanukar, and S Pohujani, and U K Sheth
November 1978, Journal of pharmaceutical sciences,
S A Dahanukar, and S Pohujani, and U K Sheth
July 1978, Clinical pharmacology and therapeutics,
S A Dahanukar, and S Pohujani, and U K Sheth
April 1955, Journal of the American Pharmaceutical Association. American Pharmaceutical Association,
S A Dahanukar, and S Pohujani, and U K Sheth
December 1981, Journal of pharmaceutical sciences,
S A Dahanukar, and S Pohujani, and U K Sheth
December 1949, Journal of the American Pharmaceutical Association. American Pharmaceutical Association,
S A Dahanukar, and S Pohujani, and U K Sheth
September 1973, Journal of pharmaceutical sciences,
S A Dahanukar, and S Pohujani, and U K Sheth
January 1981, Drug intelligence & clinical pharmacy,
S A Dahanukar, and S Pohujani, and U K Sheth
June 1975, Journal of pharmaceutical sciences,
Copied contents to your clipboard!